Processa Pharmaceuticals Inc

NASDAQ:PCSA  
2.42
+0.17 (+7.56%)
Earnings Announcements

Processa Pharmaceuticals Announces Q1 2022 Results

Published: 05/12/2022 20:26 GMT
Processa Pharmaceuticals Inc (PCSA) - Processa Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Corporate Update.
Q1 Loss per Share $0.20.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.22

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.24

More details on our Analysts Page.